PEDIATRIX MEDICAL Reports Fourth Quarter FY2022 Earnings Results on February 17 2023.
February 22, 2023

Earnings Overview
On February 17 2023, PEDIATRIX MEDICAL ($NYSE:MD) reported their financial results for the quarter ended December 31 2022. Total revenue for the period decreased by 37.6% from the corresponding quarter of the prior year, amounting to USD 29.7 million. Net income for the quarter, however, increased by 3.1% on a year-over-year basis to USD 513.8 million.
Transcripts Simplified
Fourth quarter same-unit volumes and payer mix were strong. Underlying RCM performance was a headwind, but was largely offset by an advance against older AR provided by our RCM vendor. Cost side saw variable comp within the practice, salaries and benefits, and malpractice expense was elevated for the quarter.
In 2023, we expect net revenue between $2 billion and $2.1 billion, G& A expense as a percentage of revenue of just under 12%, adjusted EBITDA of $235 to $245 million, and first quarter adjusted EBITDA of 16% to 18% of full year adjusted EBITDA. We do not anticipate any additional CARES funds in 2023.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Pediatrix Medical. More…
| Total Revenues | Net Income | Net Margin |
| 1.97k | 66.33 | 6.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Pediatrix Medical. More…
| Operations | Investing | Financing |
| 166.94 | -56.95 | -487.55 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Pediatrix Medical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.35k | 1.46k | 10.75 |
Key Ratios Snapshot
Some of the financial key ratios for Pediatrix Medical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -17.5% | -21.2% | 6.1% |
| FCF Margin | ROE | ROA |
| 7.0% | 8.6% | 3.2% |
Share Price
PEDIATRIX MEDICAL released their fourth quarter financial results from FY2022 on February 17 2023. On that day, the stock opened at $15.6 and closed at $16.7, soaring 10.9% from its previous closing price of 15.1. This significant increase demonstrates the success PEDIATRIX MEDICAL achieved during the fiscal quarter. The company has developed innovative methods of providing pediatric services while prioritizing the safety of their patients, clinicians, and families. Their success is reflective in the fourth quarter financial results and will continue to grow as they build upon their reputation of high-quality care.
The continued success of PEDIATRIX MEDICAL demonstrates their commitment to providing the best care for children and newborns. With their recent financial results, the stock appears to be trending upwards, indicating that investors are optimistic about the future of the company. PEDIATRIX MEDICAL will continue to develop innovative solutions to improving pediatric care while delivering excellent results both financially and medically. Live Quote…
Analysis
GoodWhale recently completed an analysis of PEDIATRIX MEDICAL‘s financials. Our Risk Rating for this company was high, indicating there are risks associated with both the financial and business aspects of the company. We also detected two risk warnings in their income sheet and balance sheet. If you’d like to take a closer look at our full report, make sure to register on goodwhale.com. Our comprehensive, data-driven approach will give you the information you need to make the right decisions for your investment portfolio. More…

Peers
The company offers its services to medical groups, hospitals, health plans, and other healthcare organizations. Mednax Inc has a network of over 3,000 physicians and over 200 hospitals. The company has its headquarters in Fort Lauderdale, Florida. Radius Residential Care Ltd is a provider of residential care services in the United Kingdom. The company offers its services to people with learning disabilities, mental health problems, and physical disabilities. Radius Residential Care Ltd has a network of over 100 care homes and employs over 2,000 staff. The company has its headquarters in London, England. Hanger Inc is a provider of orthotic and prosthetic services in the United States. The company offers its services to patients, hospitals, and other healthcare organizations. Hanger Inc has a network of over 700 locations and employs over 4,000 people. The company has its headquarters in Austin, Texas. Ambea AB is a provider of healthcare services in Sweden. The company offers its services to people with mental illness, physical disabilities, and substance abuse problems. Ambea AB has a network of over 60 care homes and employs over 5,000 staff. The company has its headquarters in Stockholm, Sweden.
– Radius Residential Care Ltd ($NZSE:RAD)
Radius Residential Care Ltd is a provider of high quality residential aged care services. The company has a market cap of 83.47M as of 2022 and a Return on Equity of 16.16%. Radius Residential Care Ltd operates a network of aged care facilities across Australia and New Zealand. The company is committed to providing quality care for the elderly and to meeting the needs of its residents.
– Hanger Inc ($LTS:0RNX)
Amba AB is a Swedish multinational conglomerate with a focus on healthcare and medical technology. The company has a market cap of 4.8 billion as of 2022 and a return on equity of 9.28%. Amba AB’s core businesses include medical devices, diagnostics, and pharmaceuticals. The company has a strong presence in Europe and North America and is expanding into Asia and the rest of the world.
Summary
PEDIATRIX MEDICAL reported their fourth quarter financial results for FY2022 on February 17 2023. Total revenue decreased by 37.6% year-over-year, however the net income increased by 3.1%. This drove their stock price to increase the same day showing investors approval.
Analysts suggest that the company has potential to drive growth as they have established a solid performance when it comes to net income. Investors should continue to watch for future developments as the company is going to need more than a 3.1% increase to satisfy long-term investors.
Recent Posts









